Directly Observed Highly Active Antiretroviral Therapy for HIV-Infected Children in Cambodia
- 1 June 2007
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 97 (6) , 974-977
- https://doi.org/10.2105/ajph.2005.083253
Abstract
Antiretroviral medications are becoming available for HIV-infected children in resource-limited settings. Maryknoll, an international Catholic charity, provided directly observed antiretroviral therapy to HIV-infected children in Phnom Penh, Cambodia. Child care workers administered generic antiretroviral drugs twice daily to children, ensuring adherence. Treatment began with 117 late-stage HIV-infected children; 22 died of AIDS during the first 6 months. The rest were treated for at least 6 months and showed CD4 count increases comparable to those achieved in US and European children. Staffing cost for this program was approximately US $5 per child per month, or 15% more than the price of the medications. Drug toxicities were uncommon and easily managed. Directly observed antiretroviral therapy appears to be a promising, low-cost strategy for ensuring adherent treatment for HIV-infected children in a resource-limited setting.Keywords
This publication has 10 references indexed in Scilit:
- Getting drugs to HIV-infected children in CambodiaThe Lancet, 2005
- Efficacy of Highly Active Antiretroviral Therapy in HIV-Infected Children Participating in Thailand's National Access to Antiretroviral ProgramClinical Infectious Diseases, 2005
- Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'IvoireAIDS, 2004
- Comprehensive Pediatric Human Immunodeficiency Virus Care and Treatment in Constanta, RomaniaThe Pediatric Infectious Disease Journal, 2004
- Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in ProgressClinical Infectious Diseases, 2002
- Efficacy of highly active antiretroviral therapy in HIV-1 infected childrenThe Lancet Infectious Diseases, 2002
- Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1999
- Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1The Pediatric Infectious Disease Journal, 1999
- Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choiceAIDS, 1999
- Adherence: a necessity for successful HIV combination therapy.1999